Commentary: The nature of cancer research
Steven A. Frank

TL;DR
Cancer research is characterized by a fundamental conflict between the desire to control the disease and the need to understand its underlying patterns, a divide that has persisted for decades and shapes current research directions.
Contribution
This commentary revisits Peto's 1977 analysis to shed light on the enduring conflict between control and understanding in cancer research and its impact on research discipline development.
Findings
Highlights the historical conflict between control and understanding in cancer research.
Emphasizes the importance of fundamental issues in shaping research directions.
Suggests revisiting Peto's analysis to inform current research strategies.
Abstract
Cancer research reflects an implicit conflict. On the one hand, there is an overwhelming desire to control the disease. We all wish that. On the other hand, we would like to understand why cancer follows so many clearly defined yet puzzling patterns. Why is there such regularity in the rates of progression? Why do different tissues vary so much? There should, of course, be no conflict between control and understanding. But the history of cancer research seems to say that those different goals remain oddly estranged. Peto's 1977 article locates the seeds of this conflict most clearly. He describes what is still the most powerful theoretical perspective for analyzing the causes of cancer. He presents many key unsolved puzzles within that context. He also says why most cancer researchers are not interested in these fundamental issues. The subsequent decades of research grew around this…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Genomics and Diagnostics · BRCA gene mutations in cancer · Genetic factors in colorectal cancer
